Traders purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Monday. $81.49 million flowed into the stock on the tick-up and $43.38 million flowed out of the stock on the tick-down, for a money net flow of $38.11 million into the stock. Of all stocks tracked, UnitedHealth Group had the 12th highest net in-flow for the day. UnitedHealth Group traded down ($0.86) for the day and closed at $142.13

A number of brokerages have commented on UNH. Mizuho raised their price objective on UnitedHealth Group from $150.00 to $156.00 and gave the stock a “buy” rating in a research report on Wednesday, April 20th. Wedbush reiterated an “outperform” rating and issued a $138.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, April 19th. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Leerink Swann reiterated an “outperform” rating and issued a $150.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, April 19th. Finally, Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. One investment analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $153.44.

The firm has a market cap of $135.36 billion and a PE ratio of 22.24. The firm has a 50-day moving average of $141.16 and a 200-day moving average of $130.28.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The business earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. Equities research analysts predict that UnitedHealth Group Inc. will post $7.91 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Friday, September 9th will be given a dividend of $0.625 per share. The ex-dividend date is Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.76%.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, June 16th. The stock was sold at an average price of $138.58, for a total transaction of $692,900.00. Following the sale, the director now owns 72,229 shares in the company, valued at approximately $10,009,494.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,500 shares of the business’s stock in a transaction on Friday, June 10th. The stock was sold at an average price of $139.80, for a total value of $768,900.00. Following the sale, the director now owns 59,019 shares in the company, valued at approximately $8,250,856.20. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors recently made changes to their positions in UNH. Wells Fargo & Company MN increased its position in shares of UnitedHealth Group by 12.0% in the fourth quarter. Wells Fargo & Company MN now owns 7,953,096 shares of the healthcare conglomerate’s stock valued at $935,602,000 after buying an additional 854,667 shares during the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 96.4% in the fourth quarter. Jennison Associates LLC now owns 785,534 shares of the healthcare conglomerate’s stock valued at $92,410,000 after buying an additional 385,632 shares during the last quarter. Marshall Wace LLP increased its position in shares of UnitedHealth Group by 224.0% in the fourth quarter. Marshall Wace LLP now owns 486,564 shares of the healthcare conglomerate’s stock valued at $57,240,000 after buying an additional 336,405 shares during the last quarter. Veritas Asset Management LLP increased its position in shares of UnitedHealth Group by 3.7% in the fourth quarter. Veritas Asset Management LLP now owns 4,921,507 shares of the healthcare conglomerate’s stock valued at $578,966,000 after buying an additional 175,899 shares during the last quarter. Finally, Zweig DiMenna Associates LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $16,293,000.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.